{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:56:56Z","timestamp":1784782616900,"version":"3.55.0"},"reference-count":82,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T00:00:00Z","timestamp":1437004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Currently, the pathophysiology of idiopathic Parkinson\u2019s disease is explained by a loss of mainly dopaminergic nerve cells that causes a neurotransmitter deficiency. In the final stage of the disease, there is a marked loss of neurons in the substantia nigra. In addition, Lewy bodies can be found in some of the remaining neurons, which serve as the pathological hallmark of the disease. These Lewy bodies are composed mainly of aggregated \u03b1-synuclein, a physiological presynaptic protein. Lewy bodies were thought to be the pathophysiologically relevant form of \u03b1-synuclein because their appearance coincided with neuron loss in the substantia nigra. In consequence, neuron loss was thought to be the primary step in the neurodegeneration in Parkinson\u2019s disease. On the other hand, the clinical syndrome suggests a synaptic disorder. If \u03b1-synuclein aggregation was causally linked to the pathophysiology of disease, \u03b1-synuclein pathology should be found at the synapse. As recently demonstrated, one to two orders of magnitude more \u03b1-synuclein aggregates are present in presynaptic terminals than in Lewy bodies or Lewy neurites. Degeneration of dendritic spines associated with synaptic \u03b1-synuclein aggregates has been shown to occur in human disease. In experiments, using transgenic mice or cell cultures, mild (two- to three-fold) overexpression of \u03b1-synuclein caused an altered vesicle turnover and led to a reduction in neurotransmitter release. Different approaches linked these alterations to presynaptic aggregation of \u03b1-synuclein. These findings may fundamentally change the pathophysiological concept of Parkinson\u2019s disease: not nerve cell loss, but the synaptic dysfunction of still existing nerve cells should become the focus of attention. From recent findings, it is quite evident that the death of dopaminergic neurons is a secondary event in the pathophysiology of Parkinson\u2019s disease.     <\/jats:p>","DOI":"10.3390\/biom5031467","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T10:11:44Z","timestamp":1437041504000},"page":"1467-1479","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson\u2019s Disease?"],"prefix":"10.3390","volume":"5","author":[{"given":"Walter","family":"Schulz-Schaeffer","sequence":"first","affiliation":[{"name":"Prion and Dementia Research Unit, Department of Neuropathology, University Medical Center G\u00f6ttingen, Georg-August University G\u00f6ttingen, Robert-Koch-Str. 40, G\u00f6ttingen 37075, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12046","article-title":"\u03b1-Synuclein: The long distance runner","volume":"23","author":"George","year":"2013","journal-title":"Brain Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref_3","unstructured":"Halliday, G. (2013, January 17). Is the Lewy body telling us anything useful about the pathogenesis of Parkinson\u2019s disease?\u2014To understand how the study of the Lewy body gives a profound insight into the pathogenesis of Parkinson\u2019s disease. Proceedings of the 17th International Congress of Parkinson\u2019s Disease and Movement Disorders, Sydney, Australia."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","article-title":"Lewy body-related alpha-synucleinopathy in the aged human brain","volume":"111","author":"Jellinger","year":"2004","journal-title":"J. Neural Transm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson\u2019s disease: Molecules implicated in the formation and degradation of alpha-synuclein aggregates","volume":"27","author":"Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in PD","volume":"79","author":"Milber","year":"2012","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0006-8993(97)00874-3","article-title":"Contribution of somal Lewy bodies to neuronal death","volume":"775","author":"Tompkins","year":"1997","journal-title":"Brain Res."},{"key":"ref_11","first-page":"267","article-title":"Altered neurofilament expression does not contribute to Lewy body formation","volume":"148","author":"Bergeron","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_12","first-page":"728","article-title":"Altered neurofilament expression does not contribute to Lewy body formation","volume":"149","author":"Hill","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4522(90)90389-L","article-title":"Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson\u2019s disease: An in situ hybridization study","volume":"38","author":"Hirsch","year":"1990","journal-title":"Neuroscience"},{"key":"ref_14","first-page":"373","article-title":"Pathological changes in dendrites of substantia nigra neurons in Parkinson\u2019s disease: A Golgi study","volume":"6","author":"Patt","year":"1991","journal-title":"Histol. Histopathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.53.9.2003","article-title":"Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies","volume":"53","author":"Growdon","year":"1999","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.53.6.1284","article-title":"Clinical and quantitative pathologic correlates of dementia with Lewy bodies","volume":"53","author":"Newell","year":"1999","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2000.tb06899.x","article-title":"Clinical and neuropathological correlates of dementia with Lewy bodies","volume":"920","author":"Irizarry","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004019900168","article-title":"\u03b1-Synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease","volume":"100","author":"Mattila","year":"2000","journal-title":"Acta Neuropathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","article-title":"In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution","volume":"69","author":"Weisman","year":"2007","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","article-title":"Cortical Lewy body pathology in the diagnosis of dementia","volume":"102","author":"Harding","year":"2001","journal-title":"Acta Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","article-title":"Clinical phenotype of Parkinson disease dementia","volume":"67","author":"Galvin","year":"2006","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.parkreldis.2009.02.003","article-title":"Parkinson\u2019s disease dementia: A diminished role for the Lewy body","volume":"15","author":"Libow","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1212\/WNL.0b013e318278b6a7","article-title":"Neurodegeneration in Parkinson disease: Moving Lewy bodies out of focus","volume":"79","year":"2012","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1474-4422(04)00827-0","article-title":"Lewy-body formation is an aggresome-related process: A hypothesis","volume":"3","author":"Olanow","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"Cabin","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1073\/pnas.0406283101","article-title":"Double-knockout mice for \u03b1- and \u03b2-synucleins: Effect on synaptic functions","volume":"101","author":"Chandra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and \u03b1-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","article-title":"\u03b1-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis","volume":"32","author":"Scott","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_32","first-page":"1257","article-title":"\u03b1-Synuclein: Between synaptic function and dysfunction","volume":"18","author":"DiRosa","year":"2003","journal-title":"Histol. Histopathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1038\/sj.emboj.7600451","article-title":"alpha-Synuclein produces a long-lasting increase in neurotransmitter release","volume":"23","author":"Liu","year":"2004","journal-title":"EMBO J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neurobiolaging.2008.11.001","article-title":"Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice","volume":"31","author":"Ninkina","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1523\/JNEUROSCI.2922-05.2005","article-title":"Neural activity controls the synaptic accumulation of alpha-synuclein","volume":"25","author":"Fortin","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/11.20.2395","article-title":"Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Lotharius","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1096\/fj.03-1112rev","article-title":"Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?","volume":"18","author":"Sidhu","year":"2004","journal-title":"FASEB J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","article-title":"Role of alpha-synuclein in presynaptic dopamine recruitment","volume":"24","author":"Yavich","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000113678","article-title":"Basic research on dopamine in Parkinson\u2019s disease and the discovery of the nigrostriatal dopamine pathway: The view of an eyewitness","volume":"5","author":"Hornykiewicz","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2009.06.008","article-title":"In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia","volume":"204","author":"Nikolaus","year":"2009","journal-title":"Behav. Brain Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-1331.2007.01853.x","article-title":"Classical Parkinson disease versus Parkinson complex\u2014Reflections against staging and in favour of heterogeneity","volume":"14","author":"Linazasoro","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64705-0","article-title":"The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases","volume":"156","author":"Kranefuss","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia","volume":"120","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1074\/jbc.M110551200","article-title":"Biochemical characterization of the core structure of alpha-synuclein filaments","volume":"277","author":"Miake","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2144\/000112691","article-title":"Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay","volume":"44","author":"Kramer","year":"2008","journal-title":"Biotechniques"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/abio.1993.1068","article-title":"Polyvinylpyrrolidone as a blocking agent in immunochemical studies","volume":"208","author":"Haycock","year":"1993","journal-title":"Anal. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1083\/jcb.96.5.1374","article-title":"Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation","volume":"96","author":"Huttner","year":"1983","journal-title":"J. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1533317507310565","article-title":"Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies","volume":"23","author":"Revuelta","year":"2008","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cne.20449","article-title":"Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses","volume":"483","author":"Aoki","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-8993(89)91686-7","article-title":"Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age","volume":"503","author":"Ingham","year":"1989","journal-title":"Brain Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/syn.20381","article-title":"Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson\u2019s disease","volume":"61","author":"Solis","year":"2007","journal-title":"Synapse"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn1632","article-title":"Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models","volume":"9","author":"Day","year":"2006","journal-title":"Nat. Neurosci."},{"key":"ref_55","first-page":"67","article-title":"Striatal plasticity in parkinsonism: Dystrophic changes in medium spiny neurons and progression in Parkinson\u2019s disease","volume":"70","author":"Deutch","year":"2006","journal-title":"J. Neural. Transm. Suppl."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0006-8993(88)90124-2","article-title":"Atrophy of medium spiny I striatal dendrites in advanced Parkinson\u2019s disease","volume":"455","author":"McNeill","year":"1988","journal-title":"Brain Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuroscience.2005.01.007","article-title":"Evidence of a breakdown of corticostriatal connections in Parkinson\u2019s disease","volume":"132","author":"Stephens","year":"2005","journal-title":"Neuroscience"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.WNL.0000150591.33787.A4","article-title":"Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease","volume":"64","author":"Milatovic","year":"2005","journal-title":"Neurology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuron.2004.11.016","article-title":"Bidirectional activity-dependent morphological plasticity in hippocampal neurons","volume":"44","author":"Nagerl","year":"2004","journal-title":"Neuron"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1146\/annurev.neuro.24.1.1071","article-title":"Morphological changes in dendritic spines associated with long-term synaptic plasticity","volume":"24","author":"Yuste","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., and Nussbaum, R. (2003). alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science.","DOI":"10.1126\/science.1090278"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Klein, C., and Westenberger, A. (2012). Genetics of Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med.","DOI":"10.1101\/cshperspect.a008888"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","article-title":"A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration","volume":"30","author":"Scott","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.2581-13.2014","article-title":"Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson\u2019s disease","volume":"34","author":"Spinelli","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","article-title":"Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1\u2013120): Implications for Lewy body disorders","volume":"26","author":"Tofaris","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/brain\/awq132","article-title":"SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson\u2019s disease","volume":"133","author":"Anichtchik","year":"2010","journal-title":"Brain"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1523\/JNEUROSCI.0618-11.2011","article-title":"alpha-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies","volume":"31","author":"Lim","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","article-title":"Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease","volume":"29","author":"Berg","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/mds.22207","article-title":"Nigral burden of alpha-synuclein correlates with striatal dopamine deficit","volume":"23","author":"Kovacs","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/mds.25952","article-title":"Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson\u2019s disease","volume":"29","author":"Dijkstra","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.23696","article-title":"A tale on animal models of Parkinson\u2019s disease","volume":"26","author":"Bezard","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey","volume":"292","author":"Langston","year":"1984","journal-title":"Brain Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(11)70227-7","article-title":"Modelling of Parkinson\u2019s disease in mice","volume":"10","author":"Chesselet","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/466S8a","article-title":"Parkinson\u2019s disease: A model dilemma","volume":"466","author":"Beal","year":"2010","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-010-0676-z","article-title":"Proteinase K-resistant \u03b1-synuclein is deposited in presynapses in human Lewy body disease and A53T \u03b1-synuclein transgenic mice","volume":"120","author":"Tanji","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.23795","article-title":"Neuropathology of sporadic Parkinson\u2019s disease: Evaluation and changes of concepts","volume":"27","author":"Jellinger","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/fnl.11.57","article-title":"A transgenic mouse model of dementia with Lewy bodies suggest a link between \u03b1-synuclein expression, presynaptic vesicle pathology and cognitive deficit","volume":"7","year":"2012","journal-title":"Future Neurol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/5\/3\/1467\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:49:15Z","timestamp":1760215755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/5\/3\/1467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,16]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,9]]}},"alternative-id":["biom5031467"],"URL":"https:\/\/doi.org\/10.3390\/biom5031467","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,16]]}}}